Dianthus Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| AVIDITY PARTNERS MANAGEMENT LP | 02/13/2026 | 2.10 M | $86.71 M | -34.33% | 5.57% |
| VANGUARD GROUP INC | 01/29/2026 | 2.05 M | $84.42 B | 24.74% | 5.42% |
| BLACKROCK, INC. | 02/12/2026 | 1.92 M | $78.93 M | 42.92% | 5.07% |
| STATE STREET CORP | 02/13/2026 | 1.51 M | $62.13 M | 124.67% | 3.99% |
| CITADEL ADVISORS LLC | 02/17/2026 | 1.07 M | $44.05 B | 5.47% | 2.83% |
| MARSHALL WACE, LLP | 02/13/2026 | 1.01 M | $41.56 M | 76.03% | 2.67% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 02/12/2026 | 750.14 K | $30.91 M | 11.14% | 1.98% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 676.66 K | $27.89 B | 26.14% | 1.79% |
| MILLENNIUM MANAGEMENT LLC | 02/17/2026 | 667.22 K | $27.50 M | 356.48% | 1.77% |
| TRI LOCUM PARTNERS LP | 02/17/2026 | 622.40 K | $25.65 M | 240.36% | 1.65% |
| UBS GROUP AG | 01/29/2026 | 606.62 K | $25.00 M | 342.55% | 1.61% |
| GOLDMAN SACHS GROUP INC | 02/10/2026 | 577.02 K | $23.78 B | 163.75% | 1.53% |
| BNP PARIBAS ARBITRAGE, SNC | 02/10/2026 | 475.75 K | $19.61 M | 1,275.28% | 1.26% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 465.54 K | $19.18 B | 158.60% | 1.23% |
| FRANKLIN RESOURCES INC | 02/11/2026 | 462.83 K | $19.07 M | 2.78% | 1.22% |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 02/13/2026 | 375.00 K | $15.45 M | 0.00% | 0.99% |
| VIVO CAPITAL, LLC | 02/13/2026 | 354.00 K | $14.59 M | 0.00% | 0.94% |
| LOGOS GLOBAL MANAGEMENT LP | 02/17/2026 | 315.00 K | $12.98 M | 57.50% | 0.83% |
| CANDRIAM S.C.A. | 02/13/2026 | 311.15 K | $12.82 M | 3.23% | 0.82% |
| 02/13/2026 | 297.44 K | $12.26 B | 100.00% | 0.79% | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2026 | 250.81 K | $10.34 M | 29.91% | 0.66% |
| MORGAN STANLEY | 02/13/2026 | 228.02 K | $9.40 M | 194.14% | 0.60% |
| DIMENSIONAL FUND ADVISORS LP | 02/12/2026 | 210.67 K | $8.68 M | 2,324.59% | 0.56% |
| SQUAREPOINT OPS LLC | 02/13/2026 | 207.12 K | $8.54 M | 100.00% | 0.55% |
| WALLEYE CAPITAL LLC | 02/13/2026 | 205.82 K | $8.48 M | 45.83% | 0.54% |
| NUVEEN, LLC | 02/12/2026 | 190.62 K | $7.86 M | 340.82% | 0.50% |
| BARCLAYS PLC | 02/13/2026 | 176.30 K | $7.27 M | -13.73% | 0.47% |
| PATIENT SQUARE CAPITAL LP | 02/12/2026 | 150.00 K | $6.18 M | 20.00% | 0.40% |
| ATIKA CAPITAL MANAGEMENT LLC | 02/13/2026 | 134.53 K | $5.54 M | 100.00% | 0.36% |
| ENSIGN PEAK ADVISORS, INC | 02/12/2026 | 134.42 K | $5.54 M | 0.00% | 0.36% |
| AFFINITY ASSET ADVISORS, LLC | 02/13/2026 | 115.00 K | $4.74 M | -56.12% | 0.30% |
| RHENMAN & PARTNERS ASSET MANAGEMENT AB | 02/13/2026 | 98.63 K | $4.06 M | -43.20% | 0.26% |
| NEUBERGER BERMAN GROUP LLC | 02/13/2026 | 87.78 K | $3.62 M | 100.00% | 0.23% |
| EAM INVESTORS, LLC | 02/12/2026 | 84.64 K | $3.49 M | -1.97% | 0.22% |
| BANK OF NEW YORK MELLON CORP | 02/10/2026 | 75.13 K | $3.10 M | 20.35% | 0.20% |
| AMERICAN CENTURY COMPANIES INC | 02/13/2026 | 72.77 K | $3.00 M | 16.76% | 0.19% |
| RAFFERTY ASSET MANAGEMENT, LLC | 02/13/2026 | 57.88 K | $2.39 M | 233.94% | 0.15% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 51.47 K | $2.12 M | 326.71% | 0.14% |
| PUBLIC SECTOR PENSION INVESTMENT BOARD | 02/13/2026 | 48.48 K | $2.00 M | 100.00% | 0.13% |
| TWO SIGMA INVESTMENTS, LP | 02/17/2026 | 48.40 K | $1.99 M | 100.00% | 0.13% |
| JANE STREET GROUP, LLC | 02/12/2026 | 45.83 K | $1.89 B | 100.00% | 0.12% |
| JPMORGAN CHASE & CO | 02/11/2026 | 42.64 K | $1.76 M | -37.41% | 0.11% |
| MOODY ALDRICH PARTNERS LLC | 01/30/2026 | 41.30 K | $1.70 M | -4.59% | 0.11% |
| PNC FINANCIAL SERVICES GROUP, INC. | 02/06/2026 | 37.22 K | $1.53 M | 0.00% | 0.10% |
| ALPS ADVISORS INC | 02/12/2026 | 35.21 K | $1.45 M | 125.23% | 0.09% |
| RENAISSANCE TECHNOLOGIES LLC | 02/12/2026 | 32.10 K | $1.32 M | 100.00% | 0.08% |
| TD ASSET MANAGEMENT INC | 02/10/2026 | 31.75 K | $1.31 M | 14.80% | 0.08% |
| SWISS NATIONAL BANK | 02/12/2026 | 31.40 K | $1.29 M | 100.00% | 0.08% |
| RHUMBLINE ADVISERS | 02/13/2026 | 31.03 K | $1.28 B | 19.33% | 0.08% |
| WELLS FARGO & COMPANY/MN | 02/13/2026 | 28.97 K | $1.19 M | 133.93% | 0.08% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Dianthus Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 133 institutional investors and hedge funds held shares of Dianthus Therapeutics Inc. The most heavily invested institutionals were:
Avidity Partners Management LP: 2.1 M
VANGUARD GROUP INC: 2.05 M
BlackRock, Inc.: 1.92 M
STATE STREET CORP: 1.51 M
CITADEL ADVISORS LLC: 1.07 M
MARSHALL WACE, LLP: 1.01 M
129.65% of Dianthus Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 21.45 M shares in the last 24 months. This purchase volume represents approximately $1.07 B in transactions.